Can a smartphone app lift depression? new trial aims to find out

NCT ID NCT07211984

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a digital monitoring device called Dalia can improve depression symptoms when added to usual care. About 644 adults with moderate-to-severe depression will use the device for 3 months. The main goal is to see if more people feel significantly better compared to those receiving standard care alone.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Dalia digital telemonitoring device
What this could lead to
If successful, this could offer a new way to track and improve depression care using a smartphone or tablet.
What could go wrong
This is an early-stage trial with no blinding, so results may be influenced by expectations. The device is an add-on, not a standalone treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DEPRESSED are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

Locations

  • Neurostim Luxembourg

    Paris, 75005, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.